Dr Adriana Knezic completed her PhD in the Department of Pharmacology at Monash University in 2023, where she investigated the pathophysiology and therapeutic targeting of stroke in several preclinical models. She is now a Postdoc in the Department under the mentorship of A/Prof. Brad Broughton. Her current research focuses on developing novel therapeutics for stroke, including various stem cell-based approaches, using compounds to target the organ-protective effects of alternative arms of the renin-angiotensin system (such as the AT2R) and Relaxin Family Peptide Receptors, as well as hydrogel-based delivery systems for the brain. Beyond her research, she chairs the ECR Career Development Subcommittee of the Monash Biomedicine Discovery Institute, serves on the Hypertension Australia ECR committee and is the secretary of the ASCEPT Cardiovascular SIG.